L330-0151 Screening compound: N-[(4-butoxyphenyl)methyl]-2-({3-phenyl-[1,2]oxazolo[5,4-d]pyrimidin-4-yl}oxy)acetamide

L330-0151 Screening compound: N-[(4-butoxyphenyl)methyl]-2-({3-phenyl-[1,2]oxazolo[5,4-d]pyrimidin-4-yl}oxy)acetamide
L330-0151 Screening compound: N-[(4-butoxyphenyl)methyl]-2-({3-phenyl-[1,2]oxazolo[5,4-d]pyrimidin-4-yl}oxy)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L330-0151
N-[(4-butoxyphenyl)methyl]-2-({3-phenyl-[1,2]oxazolo[5,4-d]pyrimidin-4-yl}oxy)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L330-0151

Molecular Formula

C24H24N4O4 (C24 H24 N4 O4)

Compound Name

N-[(4-butoxyphenyl)methyl]-2-({3-phenyl-[1,2]oxazolo[5,4-d]pyrimidin-4-yl}oxy)acetamide

IUPAC name

N-[(4-butoxyphenyl)methyl]-2-({3-phenyl-[12]oxazolo[54-d]pyrimidin-4-yl}oxy)acetamide

SMILES

CCCCOc1ccc(CNC(COc2ncnc3c2c(-c2ccccc2)no3)=O)cc1

InChI

InChI=1S/C24H24N4O4/c1-2-3-13-30-19-11-9-17(10-12-19)14-25-20(29)15-31-23-21-22(18-7-5-4-6-8-18)28-32-24(21)27-16-26-23/h4-12,16H,2-3,13-15H2,1H3,(H,25,29)

InChI Key

MDXMDSNXJZNYEI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27246566

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

432.48

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.189

Distribution Coefficient, logD

4.189

Water Solubility, LogSw

-4.30

Polar Surface Area

82.023

Acid Dissociation Constant (pKa)

14.26

Base Dissociation Constant (pKb)

-1.67

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

L330-0151 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

MCL1 Targeted Library (12200 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with L330-0151 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L330-0151?
Check Price and Availability of L330-0151, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L330-0151 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L330-0151
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L330-0151
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L330-0151 available by request